ARTICLEArticles
-
2025.03.28
Ayako Shoji
Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in Japan
-
2025.01.09
Kinya Kokubo
Kazuaki Yamamoto
Katsuhiko Iwasaki
Risk factors affecting quality of life in children with epilepsy and their caregivers: A secondary analysis of a cross-sectional online survey in Japan
-
2025.01.09
Kinya Kokubo
Katsuhiko Iwasaki
Ayako Shoji
Evaluation of health-related quality of life (QOL), productivity losses, and health literacy in the Japanese general population using a large-scale questionnaire database
-
2024.07.12
Kinya Kokubo
Kazuaki Yamamoto
Katsuhiko Iwasaki
Emergency management of pediatric epileptic seizures in non-hospital settings in Japan.
-
2024.02.29
Katsuhiko Iwasaki
Ayako Shoji
Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database.
-
2023.08.31
Kinya Kokubo
Katsuhiko Iwasaki
A Machine Learning Exploration of Factors Affecting Heart Failure Healthcare Costs.
-
2023.06.30
Katsuhiko Iwasaki
Ayako Shoji
Linguistic validation of Barriers to Being Active Quiz (BBAQ-21) in Japanese patients with hemophilia
-
2023.05.31
Ayako Shoji
Patient–Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians.
-
2023.05.31
Kinya Kokubo
Katsuhiko Iwasaki
A Machine Learning Exploration of Factors Affecting Pancreatic Cancer.
-
2023.03.31
Katsuhiko Iwasaki
Ayako Shoji
Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world data.